Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9616 posts found.

Opdivo

BMS halts Opdivo kidney cancer trial early

July 22, 2015 Research and Development BMS, Bristol-Myers Squibb, European Commission, Kidney cancer, opdivo, renal cell carcinoma

Bristol-Myers Squibb has stopped its Phase III study of its immunotherapy drug Opdivo in people with kidney cancer early after …
News
NHS sign

Cancer Drugs Fund assessment to be handed over to NICE

July 22, 2015 Medical Communications, Research and Development CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, NHSE, NICE, cost effectiveness, cost-effectiveness

NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …
News
rtorbett

New ABPI executive director appointed

July 21, 2015 Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Richard Corbett

The UK pharma trade body the ABPI has appointed Richard Corbett as its new executive director of commercial. Corbett will …
Appointment
Malthouse_Freeman

Parliamentary launch for UK life sciences group

July 21, 2015 Manufacturing and Production, Research and Development All Party Parliamentary Group on Life Sciences, Kit Malthouse, george freeman, government, lobbying, parliament

A Parliamentary body has been created to highlight the contribution the life sciences sector makes to the economy, and boost …
News
Sense About Science

Ruling in transparency case ‘due within days’

July 17, 2015 Research and Development EMIG, EU Clinical Trial Regulation, Ethical Medicines Industry Group, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency

A judge is set to rule on a controversial legal challenge to the requirement for the pharma industry to register …
News

It’s time the industry spoke out about legal challenge to clinical trial transparency

July 16, 2015 Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency

The judicial review brought by Richmond Pharmacology against the Health Research Authority – erroneous, a waste of public money and …
Feature

Industry awaits outcome of transparency legal challenge

July 16, 2015 Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency

A judge will today hear arguments from the Health Research Authority and campaigners who are contesting a judicial review of …
News

MRC, GSK and universities team up on inflammatory diseases

July 15, 2015 Research and Development COPD, GSK, MRC, Medical Research Council, fibrosis, inflammatory diseases

UK pharma giant GSK is partnering with the Medical Research Council, to study the biological mechanisms behind common inflammatory diseases. …
News
anderw_mackie_picture

Ergomed strengthens management team and board

July 15, 2015 Research and Development, Sales and Marketing Andrew Mackie, ergomed

UK-based drug development company Ergomed has appointed Andrew Mackie as chief business officer, and to its board as executive director.Mackie …
Appointment
The Francis Crick Institute

GSK and the Francis Crick Institute collaborate on drug R&D

July 15, 2015 Research and Development Francis Crick Institute, GSK, R&D, The Crick, medical research

The UK’s largest pharma company and the UK’s newest biomedical research facility are partnering up to begin an innovation collaboration.The …
News
Public Health England

Public Health England and Imperial Innovations boost UK life sciences sector

July 14, 2015 Manufacturing and Production, Research and Development Imperial Innovations, Public Health England, R&D, investment, life sciences, spin-puts

The Government has signed-off on the transfer of Public Health England’s drug development and production arm into a state-owned biopharma …
News
Life sciences minister George Freeman

Government launches Accelerated Access Review call to action

July 14, 2015 Research and Development Accelerated Access Review, Sir Hugh Taylor, UK, george freeman, john bell, life sciences minister

The Government is urging pharma companies to participate in the Accelerated Access Review, and will launch a website for firms …
News

Chancellor announces drug R&D funding boost in Catapult expansion

July 14, 2015 Research and Development Cambridge, Catapults, Chancellor, George Osborne, Northern Powerhouse, Precision Medicine, R&D, UK, alderley, economy

Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …
News
roche__tree

Roche posts positive mid-stage trial results for atezolizumab

July 13, 2015 Research and Development Genentech, PD-L1, Phase II, Roche, anti-PD-L1, atezolizumab, clinical trial, immuno-oncology, personalised medicine

A cancer drug in development by Roche has performed well in a mid-phase clinical trial – prompting the Swiss firm …
News

Novo Nordisk pushes forward with new diabetes drug trial

July 13, 2015 Research and Development GLP-1 agonist, Novo Nordisk, diabetes, phase III, semaglutide, type 2 diabetes

Novo Nordisk is taking the first steps towards adding another type 2 diabetes drug to its portfolio, after announcing positive …
News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026